PD-L1 Biomarkers News and reporting on PD-L1 biomarkers. Astronomy, Biology Come Together for Cancer Biomarker Discovery Premium Johns Hopkins researchers have developed a single-cell, multispectral imaging platform called AstroPath for precise pathological analysis of cancer specimens. Breast Cancer Immunotherapy Response Markers Emerge From Single-Cell Sequencing Study Researchers identified several pre-treatment markers that correlated with T-cell expansion and could be predictive of response to a PD1 inhibitor. NanoView, Beth Israel Deaconess Medical Center Launch Immuno-Oncology Biomarker Study The team will use NanoView's ExoView platform to characterize PD-L1 and other biomarkers carried by exosomes in plasma samples from patients undergoing therapy. Diaceutics, Alva10 Gathering Evidence Base for Improving PD-L1 Test Reimbursement Premium The companies will work with labs to improve payors' understanding of the costs of performing PD-L1 testing and the value it provides to patient care. FDA Approves Merck's Keytruda, Agilent CDx in PD-L1-High Triple-Negative Breast Cancer The agency approved Agilent/Dako's PD-L1 IHC test for identifying TNBC patients who are most likely to respond to Keytruda and chemo. Aug 10, 2020 T Cell Receptor Repertoire Linked to Anti-PD-1 Therapy Response in Hodgkin Lymphoma Apr 30, 2020 Washington University, BostonGene Expand Kidney Cancer Research Collaboration Nov 6, 2019 Merck, Promega Collaborate to Develop MSI CDx for Keytruda Aug 5, 2019 IncellDx Inks Chinese Collaboration, Distribution Agreements Jun 1, 2019 ASCO Studies Show Keytruda Increases Five Year Survival in NSCLC, Provides New Gastric Cancer Option Premium May 2, 2019 Arcus Biosciences, Strata Oncology Team Up to Advance Anti-PD-1 Drug Apr 10, 2019 Foundation Medicine, Flatiron Health Publish Clinical Validity of Clinico-Genomics Database Apr 9, 2019 Immunotherapy Developers, Clinical Researchers Continue to Seek New Dx Strategies Premium Jan 15, 2019 Tumor Mutation Burden Predicts Immunotherapy Benefit Across Cancers, Though Cutoffs Differ Premium Dec 5, 2018 Genentech Data Shows Breast Cancer Patient Subgroups May Benefit from Its Drugs Premium Aug 21, 2018 FDA Approves Expanded Use of Agilent Assay as Keytruda CDx for Urothelial Cancer Jun 15, 2018 PDL1 Amplifications Mark Subset of Solid Tumors, May Point to Checkpoint Blockade Response Jun 5, 2018 WIN Consortium Applies Transcriptomics to Bolster Patient Matching in Precision Oncology Study Premium Apr 17, 2018 At AACR, Immuno-Oncology Clinical Trials Offer Mixed Messages on Predictive Biomarkers Premium Sep 22, 2017 FDA Approves Merck's Keytruda, Agilent Dako CDx for Gastric Cancer Indications Aug 15, 2017 ASCO Updates NSCLC Guidelines With New Directives for Genomic Testing May 11, 2017 Which PD-L1 Assay to Use With Which NSCLC Immunotherapy? There's an Atlas for That Now Premium May 2, 2017 FDA Approves Roche's PD-L1 Test for Bladder Cancer Sep 12, 2016 Opdivo Setback May Yield Lessons for Pharma Advancing Immunotherapies With PD-L1 Testing Premium Jun 7, 2016 Researchers at ASCO See Need for More Biomarkers to Gauge Patient Response to Immunotherapies Premium Load More Breaking News Children With Autism May Have Underdeveloped Gut Microbiomes, Metagenomic Analysis Finds Kiromic BioPharma Acquires InSilico Solutions Bio-Rad Laboratories, 10x Genomics Settle IP Lawsuits, Sign Global Cross-Licensing Agreement Scope Fluidics Obtains CE Mark for PCR-Based SARS-CoV-2 Panel MeMed COVID-19 Prognostic Test Receives CE Mark ERS Genomics Licenses CRISPR IP to Japan SLC The Scan Dropped Charges The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal. More Kids The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children. PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more. Purnell Choppin Dies Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.